<DOC>
	<DOCNO>NCT00652808</DOCNO>
	<brief_summary>This study perform demonstrate treatment valdecoxib 10 mg daily ( QD ) least effective naproxen 500 mg twice daily ( BID ) , standard non-steroidal anti-inflammatory drug ( NSAID ) , take 6 week Korean subject symptomatic osteoarthritis ( OA ) knee . Secondary objective assess overall safety tolerability valdecoxib 10 mg QD take 6 week Korean subject symptomatic OA knee .</brief_summary>
	<brief_title>Double-Blind , Double Dummy , Randomized Comparison Study Evaluate Efficacy Safety Valdecoxib 10 mg Once Daily Naproxen 500 mg Twice Daily Treating Signs Symptoms Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Valdecoxib</mesh_term>
	<criteria>Korean outpatient symptomatic radiologic evidence OA knee ( diagnose accord modified American College Rheumatology criterion ) Patient 's Assessment Arthritis Pain measurement least 40 mm VAS Patients receive NSAIDs analgesic within 2 day ( within 4 day subject take oxaprozin , piroxicam full dose aspirin ) prior Baseline Visit Diagnosis inflammatory arthritis , gout , pseudogout , Paget 's disease , chronic pain syndrome , Investigator 's opinion , would interfere assessment Index Knee Symptomatic anserine bursitis acute joint trauma Index Knee Arthroscopy perform Index Knee within past 12 month Complete loss articular cartilage Index Knee Administration oral , intramuscular , intravenous , soft tissue injection corticosterosteroids within 4 week prior screen visit Administration intraarticular injection corticosteroid hyaluronic acid preparation Index Knee within 3 month 6 month , respectively</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>knee , OA patient</keyword>
</DOC>